Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Velsera
Boston, MA, United Statesvelsera.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Velsera offers commercial-stage software platforms that accelerate clinical genomics workflows and multiomic data analysis. Their CGW Plus platform streamlines variant assessment and reporting for clinical labs. The company’s integrated solutions are widely adopted by top pharma companies and diagnostic labs globally to improve R&D productivity and patient outcomes in precision medicine.
- Therapeutic areas
- OncologyRare DiseasesOther
- Modalities
- Multiomics data analysis (genomics, transcriptomics, etc.)Companion diagnostics developmentNGS assay development and validation
- Industry
- Digital Health Medical Devices
02
Partnerships
Major pharmaceutical companiesClinical diagnostic labs worldwide
Beyond the preview
Go deeper on Velsera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Velsera.